CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex

被引:136
作者
Cass, D. K. [1 ]
Flores-Barrera, E. [1 ]
Thomases, D. R. [1 ]
Vital, W. F. [1 ]
Caballero, A. [1 ]
Tseng, K. Y. [1 ]
机构
[1] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cellular & Mol Pharmacol, N Chicago, IL 60064 USA
关键词
adolescence; cannabinoid; CB1; receptor; GABA; prefrontal cortex; ventral hippocampus; SYNAPTIC-TRANSMISSION; RECOGNITION MEMORY; BRAIN-DEVELOPMENT; EXPOSURE; PSYCHOSIS; DELTA-9-TETRAHYDROCANNABINOL; SCHIZOPHRENIA; TRAJECTORIES; ASSOCIATION; ENVIRONMENT;
D O I
10.1038/mp.2014.14
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Converging epidemiological studies indicate that cannabis abuse during adolescence increases the risk of developing psychosis and prefrontal cortex (PFC)-dependent cognitive impairments later in life. However, the mechanisms underlying the adolescent susceptibility to chronic cannabis exposure are poorly understood. Given that the psychoactive constituent of cannabis binds to the CB1 cannabinoid receptor, the present study was designed to determine the impact of a CB1 receptor agonist (WIN) during specific windows of adolescence on the functional maturation of the rat PFC. By means of local field potential recordings and ventral hippocampal stimulation in vivo, we found that a history of WIN exposure during early (postnatal days - P35-40) or mid-(P40-45) adolescence, but not in late adolescence (P50-55) or adulthood (P75-80), is sufficient to yield a state of frequency-dependent prefrontal disinhibition in adulthood comparable to that seen in the juvenile PFC. Remarkably, this prefrontal disinhibition could be normalized following a single acute local infusion of the GABA-Aa1 positive allosteric modulator Indiplon, suggesting that adolescent exposure to WIN causes a functional downregulation of GABAergic transmission in the PFC. Accordingly, in vitro recordings from adult rats exposed to WIN during adolescence demonstrate that local prefrontal GABAergic transmission onto layer V pyramidal neurons is markedly reduced to the level seen in the P30-35 PFC. Together, these results indicate that early and mid-adolescence constitute a critical period during which repeated CB1 receptor stimulation is sufficient to elicit an enduring state of PFC network disinhibition resulting from a developmental impairment of local prefrontal GABAergic transmission.
引用
收藏
页码:536 / 543
页数:8
相关论文
共 48 条
[31]  
Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix
[32]   The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids:: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin [J].
Pertwee, R. G. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (02) :199-215
[33]   Adolescent Cannabinoid Exposure Permanently Suppresses Cortical Oscillations in Adult Mice [J].
Raver, Sylvina M. ;
Haughwout, Sarah P. ;
Keller, Asaf .
NEUROPSYCHOPHARMACOLOGY, 2013, 38 (12) :2338-2347
[34]   Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids [J].
Realini, N. ;
Rubino, T. ;
Parolaro, D. .
PHARMACOLOGICAL RESEARCH, 2009, 60 (02) :132-138
[35]   Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison [J].
Renard, Justine ;
Krebs, Marie-Odile ;
Jay, Therese M. ;
Le Pen, Gwenaelle .
PSYCHOPHARMACOLOGY, 2013, 225 (04) :781-790
[36]   Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats [J].
Schneider, M ;
Koch, M .
NEUROPSYCHOPHARMACOLOGY, 2003, 28 (10) :1760-1769
[37]   Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats [J].
Schneider, Miriam ;
Schoemig, Edgar ;
Leweke, F. Markus .
ADDICTION BIOLOGY, 2008, 13 (3-4) :345-357
[38]  
Schweinsburg Alecia D, 2008, Curr Drug Abuse Rev, V1, P99
[39]   Cognitive functioning of long-term heavy cannabis users seeking treatment [J].
Solowij, N ;
Stephens, RS ;
Roffman, RA ;
Babor, T ;
Kadden, R ;
Miller, M ;
Christiansen, K ;
McRee, B ;
Vendetti, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (09) :1123-1131
[40]   Spicing things up: synthetic cannabinoids [J].
Spaderna, Max ;
Addy, Peter H. ;
D'Souza, Deepak Cyril .
PSYCHOPHARMACOLOGY, 2013, 228 (04) :525-540